KNSA
NASDAQ HealthcareKiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares
Drug Manufacturers - Specialty & Generic
📊 Market Data
| Price | $46.07 |
|---|---|
| Volume | 971,754 |
| Market Cap | 3.53B |
| Beta | 0.090 |
| RSI (14-Day) | 43.9 |
| 200-Day MA | $37.16 |
| 50-Day MA | $43.70 |
| 52-Week High | $49.12 |
| 52-Week Low | $18.25 |
| P/E Ratio | 61.43 |
| Forward P/E | 26.82 |
| Price / Book | 6.19 |
🎯 Investment Strategy Scores
How KNSA scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
50/100
High dividend yield + low volatility
🚀 Moon Shot
10/100
High growth potential (high beta + oversold)
🔪 Falling Knife
22/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
61/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
52/100
Large-cap, institutional-quality stocks
Find KNSA in your text
Paste any text on the homepage — the tool will extract KNSA and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.